Publication of pivotal efficacy trials for novel therapeutic agents approved between 2005 and 2011: a cross-sectional study
about
Association of the FDA Amendment Act with trial registration, publication, and outcome reportingTime to publication of oncology trials and why some trials are never published.Number of citations 1 year after publication of trial results and their relation to medicines regulatory approval.Publication and Reporting of the Results of Postmarket Studies for Drugs Required by the US Food and Drug Administration, 2009 to 2013.Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study.
P2860
Publication of pivotal efficacy trials for novel therapeutic agents approved between 2005 and 2011: a cross-sectional study
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Publication of pivotal efficac ...... 2011: a cross-sectional study
@ast
Publication of pivotal efficac ...... 2011: a cross-sectional study
@en
Publication of pivotal efficac ...... 2011: a cross-sectional study
@nl
type
label
Publication of pivotal efficac ...... 2011: a cross-sectional study
@ast
Publication of pivotal efficac ...... 2011: a cross-sectional study
@en
Publication of pivotal efficac ...... 2011: a cross-sectional study
@nl
prefLabel
Publication of pivotal efficac ...... 2011: a cross-sectional study
@ast
Publication of pivotal efficac ...... 2011: a cross-sectional study
@en
Publication of pivotal efficac ...... 2011: a cross-sectional study
@nl
P2860
P1476
Publication of pivotal efficac ...... 2011: a cross-sectional study
@en
P2093
Nicholas S Downing
P2860
P304
P356
10.1001/JAMAINTERNMED.2014.3438
P577
2014-09-01T00:00:00Z